Top Cited Papers
Open Access
Abstract
Yellow fever virus (YFV) live attenuated vaccine can, in rare cases, cause life-threatening disease, typically in patients with no previous history of severe viral illness. Autosomal recessive (AR) complete IFNAR1 deficiency was reported in one 12-yr-old patient. Here, we studied seven other previously healthy patients aged 13 to 80 yr with unexplained life-threatening YFV vaccine–associated disease. One 13-yr-old patient had AR complete IFNAR2 deficiency. Three other patients vaccinated at the ages of 47, 57, and 64 yr had high titers of circulating auto-Abs against at least 14 of the 17 individual type I IFNs. These antibodies were recently shown to underlie at least 10% of cases of life-threatening COVID-19 pneumonia. The auto-Abs were neutralizing in vitro, blocking the protective effect of IFN-α2 against YFV vaccine strains. AR IFNAR1 or IFNAR2 deficiency and neutralizing auto-Abs against type I IFNs thus accounted for more than half the cases of life-threatening YFV vaccine-associated disease studied here. Previously healthy subjects could be tested for both predispositions before anti-YFV vaccination.
Funding Information
  • Howard Hughes Medical Institute
  • The Rockefeller University
  • St. Giles Foundation
  • National Institutes of Health (R01AI088364)
  • National Center for Advancing Translational Sciences
  • National Institutes of Health (UL1 TR001866)
  • Emergent Ventures
  • George Mason University
  • Yale Center for Mendelian Genomics
  • National Human Genome Research Institute (UM1HG006504, U24HG008956)
  • French National Research Agency (ANR-10-IAHU-01)
  • Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence (ANR-10-LABX-62-IBEID)
  • French Foundation for Medical Research (EQU201903007798)
  • French Foundation for Medical Research
  • French National Research Agency
  • ANRS-COV05
  • Square Foundation
  • Grandir–Fonds de Solidarité pour l’Enfance
  • SCOR Corporate Foundation for Science
  • Institut National de la Santé et de la Recherche Médicale
  • University of Paris
  • National Institute of Allergy and Infectious Diseases
  • National Institutes of Health
  • Institut National de la Santé et de la Recherche Médicale
  • Imagine Institute
  • Fondation Bettencourt Schueller
  • French Foundation for Medical Research (EA20170638020)
  • Imagine Institute
  • Fondation Bettencourt Schueller
  • National Institutes of Health
  • National Institute of Allergy and Infectious Diseases (1R01AI124690)

This publication has 53 references indexed in Scilit: